Osteoporosis & bone health

Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan

Osteoporos IntPublished Retrospective cohort study

Main finding · ONJResult — go to the resultHazard ratio 0.581 95% CI 0.33–1.04

Authors' conclusion

In osteoporotic patients, after 2 years of use, the likelihood of ONJ being induced by denosumab is lower than that of BPs, and the difference increases with time.

Study context

Population
Patients aged > 40 years with osteoporosis, January 2010–December 2018, multiple institutions in Taiwan3,665 per group after propensity score matching (PSM)
Participants
8,962 patients
Exposure
Denosumab vs bisphosphonates in osteoporosis
  • Denosumabn = 3,665
  • Bisphosphonates (BPs)n = 3,665reference
Outcome
Long-term risk of ONJ
Methodological detailsmulti-institutional, propensity score matched (1:1), Cox proportional hazards model, Kaplan-Meier method
  • Multi-institutional
  • Propensity score matched (1:1)
  • Cox proportional hazards model
  • Kaplan-Meier method

Main finding

ONJ

Hazard ratio

0.581

95% CI 0.33–1.04

P = 0.07

By group

Denosumabvs BPs
HR 0.581 (95% CI 0.33–1.04); P = 0.07

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeP value
Cumulative incidence of ONJ, first and second years of drug useP = 0.062
Cumulative incidence of ONJ, from the third year onwardsP = 0.022

Cumulative incidence of osteonecrosis of the jaw (ONJ), first and second years of drug use

Cumulative incidence rates similar in both groups

Cumulative incidence of ONJ, from the third year onwards

Cumulative incidence rates significantly different

Severity of ONJ

Not significantly different between the two groups

Original publication

Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan. Osteoporos Int. Published 16 June 2023. doi:10.1007/s00198-023-06818-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.